SHERRY HOUSLEY: Open Payments
NPI 1700268042 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 36 payments from 13 companies in 2025. Trend: 2023 $128 · 2024 $221 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $188 |
| CSL Behring | 6 | $179 |
| Novartis Pharmaceuticals Corporation | 6 | $156 |
| GENZYME CORPORATION | 3 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Pharming Healthcare, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Greer Laboratories, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| Optinose US, Inc. | 1 | $25 |
Products named: DUPIXENT, Andembry, TEZSPIRE, CUVITRU, RUCONEST, ORALAIR, Rhapsido, Haegarda.
Industry payments across FL — which companies pay providers there.
